baber/WOPTO huggingface dataset:
Patent PT-1758555-E (PT)
Title: Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel
Inventor: SCHEFFLER ARMIN
IPC: A61K9/10
Filed: 2005-06-21
Abstract: The invention relates to an oleogel-forming agent which comprises at least one highly dispersed triterpene. The invention also relates to an oleogel which comprises a nonpolar liquid in an amount ranging from 80% by weight to 99% by weight based on the total weight of the oleogel and an oleogel-forming agent comprising a highly dispersed triterpene in an amount ranging from 1% by weight to 20% by weight based on the total weight of the oleogel. The invention also relates to a method for producing an oleogel.
Patent PT-1700972-E (PT)
Title: Stabilising brace for builders` trestles
Inventor: CLEAR LIAM
IPC: E04G1/32
Filed: 2005-04-28
Abstract: A bracket 60 for securing a first kickboard 62 transversely of a second kickboard 54 comprises a socket 64 for receiving an end of the first kickboard and a clip 70 for securing the bracket to the second kickboard, the clip comprising a lateral extension 76 aligned with the longitudinal axis of the second kickboard for stabilising the bracket thereon.
Patent PT-1888643-E (PT)
Title: Anti-gm-csf antibodies and uses therefor
IPC: C07K16/24
Filed: 2006-05-17
Abstract: The present invention provides recombinant antigen-binding regions, antibodies and functional fragments thereof that are specific for GM-CSF, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, inflammatory diseases such as rheumatoid arthritis. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of GM-CSF in the progression of various disorders. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.
Patent PT-1948166-E (PT)
Title: Carbazole derivatives as functional 5-ht6 ligands
Inventor: JASTI VENKATESWARLU
IPC: A61P25/00
Filed: 2006-06-09
Abstract: Carbazole derivatives of formula (I), useful in treatment of a CNS disorders related to or affected by the 5-HT6 receptor are described. The pharmacological profile of these compounds includes high affinity binding with 5-HT6 receptor along with good selectivity towards the receptor. Stereoisomers, the salts, methods of preparation and medicines containing the carbazole derivatives are also described.
Patent PT-1933768-E (PT)
Title: Accomodative intraocular lens system
Inventor: ZHANG XIAOXIAO
IPC: A61F2/16
Filed: 2006-08-29
Abstract: A two optic accommodative lens system. The present invention also contemplates the use of a cam mechanism to adjust the distance power via adjustment of the dual lens separation when the eye is at distance vision stasis. The cam mechanism allows for distance/base power adjustment as needed.
Patent PT-1954639-E (PT)
Title: Device for heating furnace installations
Inventor: HOFF KLAUS-UWE
IPC: C03B29/00
Filed: 2006-11-24
Abstract: In apparatus for heating up a furnace plant (10), having at least one furnace cavity (11), a burner (20) in which gas-air mixture (21) is burned to generate hot gaseous medium to be fed to the cavity and an aerator (30) for circulating air (14) in the cavity, the burner is a flat burner located in the furnace cavity sufficiently close to the aerator for the hot medium to be distributed directly from the aerator.
Patent PT-1820722-E (PT)
Title: Automatic bicycle storage system
Inventor: GAGOSZ JEAN-CLAUDE
IPC: B62H5/00
Filed: 2007-02-19
Abstract: The system has a set of cycles each carrying a locking part (10). Each of a set of fixed locking stations has a strike adapted to receive the locking part of one of the cycles and to retain the locking part. Each cycle has an anti-theft device (48) for preventing locking of the cycle on one of the locking stations when the anti-theft device is in immobilzation position of the cycle.
Patent PT-2164906-E (PT)
Title: Aqueous suspensions of fine particulate fillers, method for producing the same and use thereof for producing papers having a high filler content and a high dry strength
Inventor: HAEHNLE HANS-JOACHIM
IPC: C09C1/02
Filed: 2008-07-04
Abstract: Aqueous slurries of finely divided fillers which are at least partly coated with a composition comprising at least one water-soluble amphoteric copolymer and at least one latex.
Patent PT-2111876-E (PT)
Title: Crosslinked polymer compositions and methods for their use
Inventor: RHEE WOONZA M
IPC: C08B37/00
Filed: 1996-12-18
Abstract: A composition comprising a first synthetic polymer having m nucleophilic groups, and a second synthetic polymer having n electrophilic groups, wherein said nucleophilic groups and said electrophilic groups are capable of reacting to form covalent bonds between the first synthetic polymer and the second synthetic polymer which results in formation of a three-dimensional matrix, wherein m and n are each greater than or equal to three, wherein the nucleophilic groups comprise thiol groups, and wherein the electrophilic groups comprise two or more succinimidyl groups.
Patent PT-2384997-E (PT)
Title: Single portion cartridge with ground coffee for producing a coffee drink
Inventor: SCHMED ARTHUR
IPC: B65D81/34
Filed: 2005-01-13
Abstract: Cartridge contains one serving of coffee powder, cartridge body with bottom and cover (4) portions, gas tight foil (21) covering the passage (22), and filter (2) inside the cartridge body between the coffee powder and passage in the bottom portion of cartridge body. The bottom portion of cartridge body has passage.
Patent PT-598682-E (PT)
Inventor: WUTHRICH DANIEL
IPC: H04H60/58
Filed: 1993-11-15
Abstract: To evaluate the audience behaviour to radio or TV programmes, listening samples are taken at particular times. These listening samples can detect the sound impressions actually received by a test person, on the one hand. For this purpose, the test person carries a portable monitor on his person. Furthermore, the receiving sets themselves can also carry such monitors, in which arrangement, apart from the acoustic pick-up of the listening samples, a direct electrical connection to the monitor is also possible. The listening samples are converted into digital form, compressed, transformed and, if necessary, coded by adequate methods. The listening samples are transmitted at relatively large time intervals to a central station where the listening samples are correlated with samples from the monitored programmes which are picked up at the same time. <IMAGE>
Patent PT-646593-E (PT)
Inventor: STACHE ULRICH
IPC: A61K31/56
Filed: 1994-09-29
Abstract: Corticoid 17,21-dicarboxylic esters and corticoid 17-carboxylic esters 21-carbonic esters of the formula I <IMAGE>  with     A equal to CHOH and CHClm CH2, C=0, 9(11) double bond;   Y equal to H, F, Cl;   Z equal to H, F, methyl,   R(1) equal to aryl, hetaryl;   R(2) equal to alkyl,   R(3) equal to H, methyl are described. They are obtained, inter alia, by reacting a compound of the formula II <IMAGE> in which R(5) is equal to OH, with an activated carboxylic acid of the formula III <IMAGE>   They have very high local and topical antiinflammatory activity and show a very good ratio of local to systemic antiinflammatory effect. They are used inter alia as agents for treating inflammatory dermatoses.
Patent PT-652226-E (PT)
Inventor: VEMISHETTI PURUSHOTHAM
IPC: C07F9/6561
Filed: 1994-11-03
Abstract: Etoposide phosphate is prepared by coupling dibenzyl 4'-demethyl-4-epipodophyllotoxin-4'-phosphate with 2,3-di-O-benzyl-4,6-O-ethylene- alpha , beta -D-glucopyranose in a solvent and subsequently removing the protecting groups. The tetra-benzyl protected etoposide phosphate is recrystallized from methanol or directly crystallized from acetonitrile by adding methanol to yield substantially the pure C-1''- beta  form. The benzyl protecting groups are simultaneously removed by hydrogenation to produce etoposide phosphate in high yields. In a further embodiment, etoposide phosphate is treated with a phosphatase enzyme to yield etoposide.
Patent PT-668777-E (PT)
Title: Prostate-specific membrane antigen
Inventor: ISRAELI RON S
IPC: A61K48/00
Filed: 1993-11-05
Abstract: This invention provides for an isolated mammalian nucleic acid molecule encoding a mammalian prostate-specific membrane antigen. This invention provides for nucleic acid probes which specifically hybridize with the nucleic acid molecule encoding said antigen. This invention provides for a method of detecting hematogenous micrometastic tumor cells of a subject performing the polymerase chain reaction (PCR) on samples of the subjet using primers of said antigen. This invention provides for methods to identify ligands which bind to said antigen. This invention provides for the prevention and/or treatment of prostate tumor growth.
Patent PT-640065-E (PT)
Inventor: WARRELOW GRAHAM JOHN
IPC: A01N43/40
Filed: 1994-03-09
Abstract: Compounds of general formula (1) are described wherein Y is a halogen atom or a group -OR1, where R1 is an optionally substituted alkyl group; X is -O-, -S- or -N(R7)-, where R7 is a hydrogen atom or an alkyl group; R2 is an optionally substituted cycloalkyl or cycloalkenyl group; R3 and R4, which may be the same or different, is each a hydrogen atom or an alkyl, -CO2R8 (where R8 is a hydrogen atom or an alkyl, aryl, or aralkyl group), -CONR9R10 (where R9 and R10 which may be the same or different is each a hydrogen atom or an alkyl, aryl or aralkyl group), -CSNR9R10, -CN, -CH2CN group; Z is -(CH2)n- (where n is zero or an integer 1, 2 or 3; R5 is an optionally substituted monocyclic or bicyclic aryl group optionally containing one or more heteroatoms selected from oxygen, sulphur or nitrogen atoms; R6 is a hydrogen atom or a hydroxyl group; and the salts, solvates, hydrates, prodrugs and N-oxides thereof. Compounds according to the invention are potent and selective phosphodiesterase type IV inhibitors and are useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present.
Patent PT-689536-E (PT)
Inventor: CHENARD BERTRAND LEO
IPC: C07D211/22
Filed: 1994-02-15
Abstract: Compounds of formula (I) where R1 is of formulae (II), (III), or (IV), or (V); R2 is -R4, -O-R4, -O-S(O)2-R4, -NR4R5, R4-(CH2)b-NH(C=X)-(CH2)c-, R4-(CH2)b-O(C=O)NH-(CH2)c-(C=O)NH-, R4-(C=O)NH-(C=O)NH-, -(CH2)b-NH(C=X)-(CH2)c-R4, R4-(CH2)b-O(C=O)-(CH2)c-, -(CH2)b-O(C=O)-(CH2)c-R4, -NH(C=X)NH-R4, R4-O(C=O)O-, -O(C=O)NH-R4, R4-O(C=O)NH-, -(CH2)b-(C=O)-(CH2)c-R4, -NH-S(O)2-R4, -C(OH)R4R5, -CH(OH)-R4, -(C=O)-NR4R5, -CN, -NO2, substituted C1 to C6 alkyl, substituted or unsubstituted C1 to C6 alkenyl, or substituted or unsubstituted C1 to C6 alkynyl, said substituted moieties substituted with a moiety of the formulae -R4, -R4R5, -O-R4, or -S(O)d-R4; R3 is hydrogen, C1 to C6 alkyl, C1 to C6 alkylaryl, or aryl; R4 and R5 are each independently (XV), (XVI), (XVII), hydrogen, -CF3, C1 to C6 alkyl, C1 to C6 alkylaryl, with the proviso that when R2 is -R4 or -OR4, R4 is not hydrogen or C1 to C6 alkyl. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and antagonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent PT-696560-E (PT)
Inventor: MARABINI ANNA MARIA
IPC: C04B35/20
Filed: 1995-08-08
Abstract: A process for preparing ceramic materials having particular properties starting from asbestos wastes is described. The so obtained ceramic materials are also described.
Patent PT-837990-E (PT)
Inventor: GRANBOM BO
IPC: F15B15/26
Filed: 1997-03-26
Abstract: PCT No. PCT/SE97/00536 Sec. 371 Date Dec. 9, 1997 Sec. 102(e) Date Dec. 9, 1997 PCT Filed Mar. 26, 1997 PCT Pub. No. WO97/44587 PCT Pub. Date Nov. 27, 1997A brake for linear movement devices comprising a device. The brake means includes a bar which extends parallel with the path of movement of the device and which accommodates a pressurizable hose-like element that extends along the bar. The invention is characterized by a slat spring accommodated in the bar and extending on one side of the hose-like element, a brake disposed along the slat spring and movable transversely to the longitudinal direction of the hose-like element and the spring and located adjacent one longitudinally extending edge of the spring, for movement transversely to the longitudinal direction and essentially in the plane of the spring when the hose-like element is placed under pressure and the spring is flexed outwardly. The brake also includes a slide shoe which is guided in the rail and connected to the device and actuable by the brake device that is movable towards the slide shoe.
Patent PT-925008-E (PT)
Inventor: GRAEBE KURT
IPC: A61G5/10
Filed: 1997-05-21
Abstract: A composite foam base air cell module cushion having a water resistant skin, a contoured foam base designed to relieve pressure on the trochanters and the ischia and an air cell module having two sets of air cells, each partially filled, positioned inside the foam base in a chamber beneath the rear of the base. The skin is of two layer construction with a two-way stretch outer layer and a water impervious inner layer. The bottom of the base is covered with a water impervious sheet and the edges are secured to the edges of the top skin covering. The air cell is made by placing the preformed top into molds smaller in depth than the air cells to partially collapse the air cells before a base is applied to the top to close the open ends of the air cells and trap air therein.
Patent PT-948538-E (PT)
Title: Analysis and separation of platelet-derived growth factor proteins
Inventor: KUNITANI MICHAEL
IPC: C12N1/19
Filed: 1997-12-12
Abstract: Methods for improving purification and quantification of platelet-derived growth factor (PDGF) proteins having structural heterogeneity are provided. Preparation of substantially pure isoforms of these proteins is achieved using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. A reverse charged capillary zone electrophoresis method enables quantification of substantially pure isoforms of these proteins resulting from endoproteolytic post-translational modifications. Compositions of the invention are substantially purified isoforms of secreted PDGF proteins having structural heterogeneity, more particularly purified intact, single-clipped, and double-clipped isoforms of recombinant PDGF-BB. Pharmaceutical compositions comprising at least one of these substantially purified recombinant PDGF isoforms and methods for their use in promoting wound healing are also provided.
Patent PT-942952-E (PT)
Inventor: SCHMIDT STEVEN L
IPC: C08G63/80
Filed: 1997-12-05
Abstract: The present invention relates to a process for controlling the change of intrinsic viscosity and transesterification during solid stating of a polyethylene terephthalate (PET) and polyethylene naphthalate (PEN) blend, with an effective amount of an alkylene glycol compound. The process enables the production of a copolymer based on predefined initial and final IV's and final transesterification level, by varying the solid-stating time and/or effective amount of alkylene glycol. In one embodiment, a relatively greater amount of post-consumer PET (e.g., 70%) having an IV of on the order of 0.72-0.73, is incorporated in the blend to provide a final IV on the order of 0.80-0.85, and a moderate, controlled level of transesterification; the blend is used to injection mold a sleeve layer of a preform. In another embodiment, a substantially transparent neck finish for a preform is made from a PEN/PET blend having an amount of alkylene glycol which enables substantial transesterification, without excessive increase in IV.
Patent PT-965729-E (PT)
Inventor: SOKOL BERND
IPC: F01D5/32
Filed: 1999-05-06
Abstract: The lock (2) has a filler part (5) with a contour matching the blade foot (12) supported against a bearer edge (3) in the turbine blade (1) via a fitting part. A protrusion (4) in the base region of the lock provides axial support for the filler part. The fitting part has a slot into which a wedge can be pressed to spread the fitting part.
Patent SG-43782-G (SG)
Title: Electronic timepiece
IPC: G04G5/00
Filed: 1982-09-11
Abstract: An electronic timepiece having an A.M. and P.M. display function. The characters A or P are displayed during time setting or correction by one discretionary display element of a plurality of display elements normally used for displaying time.
Patent SG-54290-G (SG)
Title: Hydrocarbon conversion catalyst containing alkali metal components
IPC: C07C5/333
Filed: 1990-07-11
Abstract: A novel hydrocarbon conversion catalyst, a method of preparation of this catalyst and a process for its use are disclosed. The catalyst comprises a platinum group component, a Group IVA component and a bifurcated alkali component on a carrier material. The bifurcated alkali component comprises about 0.05 to about 2 wt. % of lithium and about 0.05 to about 3 wt. % potassium, based on weight of the composite. The catalyst has particular utility as a hydrocarbon dehydrogenation catalyst.
Patent IE-35964-L (IE)
Title: Cephalosporin complexes
IPC: C07D501/20
Filed: 1972-01-10
Abstract: 1336802 Cephalosporin solvates ELI LILLY & CO 19 Jan 1972 [20 Jan 1971] 2657/72 Heading C2A Novel cephalosporin complexes of N,N- dimethylformamide (DMF) or N,N-dimethylacetamide (DMA) with a cephalosporin acid (which is defined as being any compound having the cephem ring structure with a carboxylic acid group attached in the 4-position of the dihydrothiazine ring) are prepared by: (a) mixing DMF or DMA with an ester or salt thereof of the cephalosporin acid in which the ester group is removable by treatment with a reducing agent in an acidic medium; (b) treating the mixture with a reducing agent in acidic medium to remove the ester group; and (c) adding a basic substance to raise the pH sufficiently to precipitate the desired complex. The preferred cephalosporin acids have the formula wherein R<SP>1</SP> is hydrogen or an acyl group of formula in which B is -NH 2 and W is phenyl 3- or 4- hydroxyphenyl, 4 - (α - amino - C 1 to C 3 alkyl)- phenyl, 4 - chlorophenyl, 3 - chloro- or 3,5- dichloro - 4 - hydroxyphenyl, 2- or 3 - thienyl, or sydnonyl; and A is hydrogen, -O-CO- (C 1 to C 4 alkyl), -O-CO- (C 4 to C 7 cycloalkyl), or -X-Z where X is O or S and Z is C 1 to C 4 alkyl, 1,3,4-thiadiazol-2-yl, or 1-methyl- 1H - tetrazol - 5 - yl. When the ester of the cephalosporin acid contains a free amino group, this is preferably blocked, before carrying out step (a) above, with a blocking group which is removable by acidic hydrolysis, subsequent removal of this blocking group being effected by the acidic medium used in step (b). The cephalosporin acid complex from step (c) may be purified by (d) dissolution in acidified DMF or DMA which may contain up to 40% by volume of a miscible polar liquid (e.g. water) and then (e) adding a base to reprecipitate the purified complex. The complex may be converted to the free cephalosporin acid by (f) dissolving in acidified water, heating to 40 to 70 C. and then (g) adding a base to bring the solution to the isoelectric pH of the cephalosporin, when the latter precipitates in the zwitterion form. The process (a)-(g) provides a means for obtaining pure cephalosporin acids from their impure solutions. Pharmaceutical compositions comprise an antibiotic cephalosporin, that has been prepared by the procedure (a) to (g) above, together with a suitable carrier.
[GB1336802A]
Patent IE-790183-L (IE)
Title: Assembling electrical circuits
IPC: H05K13/00
Filed: 1979-01-31
Abstract: A circuit board 1 provided with terminal receiving holes 6 is to be provided with components. The component positions are visually indicated to the assembler by a display device. A light spot is traced rapidly in a pattern characterising each component and positioned to indicate the relevant holes 6 in accordance with a predetermined assembly program. image patterns such as 2', 3' or 4' may be achieved. The image is traced sufficiently frequently that the assembler perceives a static image. <IMAGE>
Patent IE-38834-L (IE)
Title: Fungicidal agents
IPC: C07D233/60
Filed: 1974-02-08
Abstract: Compositions containing and methods of using 1-ethylimidazoles of the formula (I) R1 ¦¦ CH2-C-Y-R2 ¦ X-R3 in which R1 and R3 each individually is hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkenyl, optionally substituted aryl or optionally substituted aralkyl, R2 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, optionally substituted aryl or optionally substituted aralkyl, Y is oxygen or sulfur, and X is a keto group or a functional derivative of a keto group, AS SUCH OR IN THE FORM OF SALTS, FOR COMBATING FUNGI.
[US3914427A]
Patent IE-790262-L (IE)
Title: Laminated packaging articles
IPC: C08L33/00
Filed: 1979-02-12
Abstract: The invention pertains to the field of packaging and to a coating composition composed of a polyvinyl alcohol solution and a polymer latex for imparting gas and flavor tight packaging. (From US4363840 A) [FR2421928A1]
Patent IE-780280-L (IE)
Title: Imidazole derivatives
IPC: C07D233/84
Filed: 1978-02-08
Abstract: Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones useful for treating arthritis and related diseases.
[US4182769A]
Patent IE-790694-L (IE)
Title: Benzophenone hydrazone pesticides.
IPC: A01N47/34
Filed: 1979-08-08
Abstract: Compounds of formula I <IMAGE> in which m is 0 and n is 0 or m is 1 and n is 0 or 1; p is 0, 2 or 3, x is 0 or 1; R<1>, R<5> and R <7> are halogen, alkyl, haloalkyl, or alkoxy or R<1> and an adjacent R<5> group together with the benzene to which they are attached form a naphthyl group; R<2> and R<4> may be the same or different and are hydrogen, alkyl, acyl, an ester or thioester group, optionally substituted carbamoyl or optionally substituted thiocarbamoyl, or R<2> and R<4> together with the nitrogen to which they are attached form a 5 to 7 membered ring which may optionally contain one or more heteroatoms; R<3> is optionally substituted alkyl, alkenyl, N,N- dialkylamino, or phenyl optionally substituted by alkyl or halogen; with the proviso that when p is 0, R<2> and R<4> are not both hydrogen; have pesticidal activity, especially against insects and acarids, and pesticidal compositions and methods are described. Methods of making the compounds and novel intermediates are also described.
[GB2015508A]
Patent IE-830834-L (IE)
Title: Synthetic cork for container
IPC: B29C43/00
Filed: 1983-04-12
Abstract: A composition for forming a molded article having the external appearance resembling that of natural cork which comprises, a thermoplastic resinous material as the major ingredient thereof, a caramel colorant which is present in an amount sufficient to impart to the thermoplastic resinous material the color of natural cork, and a blowing agent, said thermoplastic resinous material being compatible with the caramel colorant and having a processing temperature which is not so high as to degrade the caramel colorant during the molding operation.